Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Higher baseline interleukin-1β and TNF-α hamper antidepressant response in major depressive disorder
Francesco Benedetti, Sara Poletti, Benedetta Vai, et al.
European Neuropsychopharmacology (2020) Vol. 42, pp. 35-44
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Selected Biomarkers of Depression: What Are the Effects of Cytokines and Inflammation?
Stefan Harsanyi, Ida Kupcová, Ľuboš Danišovič, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 578-578
Open Access | Times Cited: 148
The NLRP3 inflammasome in depression: Potential mechanisms and therapies
Cong‐Yuan Xia, Yuxuan Guo, Wenwen Lian, et al.
Pharmacological Research (2022) Vol. 187, pp. 106625-106625
Open Access | Times Cited: 87
Inflammatory mediators in major depression and bipolar disorder
Sara Poletti, Mario Gennaro Mazza, Francesco Benedetti
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 29
Low-dose interleukin 2 antidepressant potentiation in unipolar and bipolar depression: Safety, efficacy, and immunological biomarkers
Sara Poletti, Raffaella Zanardi, Alessandra Mandelli, et al.
Brain Behavior and Immunity (2024) Vol. 118, pp. 52-68
Open Access | Times Cited: 25
Antidepressant psychopharmacology: is inflammation a future target?
Francesco Benedetti, Raffaella Zanardi, Mario Gennaro Mazza
International Clinical Psychopharmacology (2022) Vol. 37, Iss. 3, pp. 79-81
Closed Access | Times Cited: 39
Association between Diffusion Tensor Imaging, inflammation and immunological alterations in unipolar and bipolar depression: A review
Rosario Aronica, Paolo Enrico, Letizia Squarcina, et al.
Neuroscience & Biobehavioral Reviews (2022) Vol. 143, pp. 104922-104922
Closed Access | Times Cited: 31
BNIP3L/NIX-mediated mitophagy alleviates passive stress-coping behaviors induced by tumor necrosis factor-α
Jia-Jing Lu, Pengfei Wu, Jin‐Gang He, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 12, pp. 5062-5076
Closed Access | Times Cited: 19
Selective association of cytokine levels and kynurenine/tryptophan ratio with alterations in white matter microstructure in bipolar but not in unipolar depression
Stefano Comai, Elisa Melloni, Cristina Lorenzi, et al.
European Neuropsychopharmacology (2021) Vol. 55, pp. 96-109
Closed Access | Times Cited: 40
Statins in Depression: An Evidence-Based Overview of Mechanisms and Clinical Studies
Riccardo De Giorgi, Nicola Rizzo Pesci, Alice M. G. Quinton, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 37
White matter integrity and pro-inflammatory cytokines as predictors of antidepressant response in MDD
Sigrid Breit, Elena Mazza, Sara Poletti, et al.
Journal of Psychiatric Research (2023) Vol. 159, pp. 22-32
Open Access | Times Cited: 14
Neutrophil to lymphocyte ratio and antidepressant treatment response in patients with major depressive disorder: Effect of sex and hippocampal volume
Marco Paolini, Y. Harrington, Laura Raffaelli, et al.
European Neuropsychopharmacology (2023) Vol. 76, pp. 52-60
Closed Access | Times Cited: 12
Post-COVID Trajectory of Pentraxin 3 Plasma Levels Over 6 Months and Their Association with the Risk of Developing Post-Acute Depression and Anxiety
Rebecca De Lorenzo, Mario Gennaro Mazza, Clara Sciorati, et al.
CNS Drugs (2024) Vol. 38, Iss. 6, pp. 459-472
Closed Access | Times Cited: 4
Circulating inflammatory markers impact cognitive functions in bipolar depression
Sara Poletti, Mario Gennaio Mazza, F. Calesella, et al.
Journal of Psychiatric Research (2021) Vol. 140, pp. 110-116
Closed Access | Times Cited: 26
High S100B Levels Predict Antidepressant Response in Patients With Major Depression Even When Considering Inflammatory and Metabolic Markers
Ricard Navinés, Giovanni Oriolo, Igor Horrillo, et al.
The International Journal of Neuropsychopharmacology (2022) Vol. 25, Iss. 6, pp. 468-478
Open Access | Times Cited: 17
Natural products target pyroptosis for ameliorating neuroinflammation: A novel antidepressant strategy
Guangheng Zhang, Ruirui Shang, Xia Zhong, et al.
Phytomedicine (2025) Vol. 138, pp. 156394-156394
Closed Access
Effects of kynurenine pathway metabolites on choroid plexus volume, hemodynamic response, and spontaneous neural activity: A new mechanism for disrupted neurovascular communication and impaired cognition in mood disorders
B. Bravi, Chiara Vitale, Palladini Mariagrazia, et al.
Brain Behavior and Immunity (2025) Vol. 125, pp. 414-427
Closed Access
Exploring the prospective association of serum interleukin-1β and brain-derived neurotrophic factor with antidepressant treatment response
C.K. Cho, Ji Hyeon Jeon, Hee-Ju Kang, et al.
European Neuropsychopharmacology (2025) Vol. 95, pp. 33-39
Closed Access
New biomarkers in mood disorders: Insights from immunopsychiatry and neuroimaging
Francesco Benedetti, Benedetta Vai
European Neuropsychopharmacology (2023) Vol. 69, pp. 56-57
Open Access | Times Cited: 9
Breaking free from the inflammatory trap of depression: Regulating the interplay between immune activation and plasticity to foster mental health
Igor Branchi, Aurelia Viglione, Benedetta Vai, et al.
Neuroscience Applied (2023) Vol. 3, pp. 103923-103923
Open Access | Times Cited: 9
Biomarkers of stress resilience: A review
Pasquale Paribello, Igor Branchi, Aurelia Viglione, et al.
Neuroscience Applied (2024) Vol. 3, pp. 104052-104052
Open Access | Times Cited: 3
Mood-congruent negative thinking styles and cognitive vulnerability in depressed COVID-19 survivors: A comparison with major depressive disorder
Francesco Benedetti, Mariagrazia Palladini, G. D'Orsi, et al.
Journal of Affective Disorders (2022) Vol. 308, pp. 554-561
Open Access | Times Cited: 12
Pharmacological anti-inflammatory treatment in children and adolescents with depressive symptoms: A systematic-review and meta-analysis
Jasper Vöckel, Anna Markser, Lisa Wege, et al.
European Neuropsychopharmacology (2023) Vol. 78, pp. 16-29
Open Access | Times Cited: 7
Antidepressant chronotherapeutics normalizes prefrontal 1H-MRS glutamate in bipolar depression
Elisa Melloni, B. Bravi, Sara Poletti, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 119, pp. 110606-110606
Closed Access | Times Cited: 11
Swimming exercise ameliorates depressive-like behavior by anti-inflammation activity, rebalancing gut Escherichia coli and Lactobacilli
Zifan Ding, Longfei Du
Brain Research (2022) Vol. 1797, pp. 148113-148113
Closed Access | Times Cited: 11
One year follow-up on a randomized study investigating serratus anterior muscle and pectoral nerves type I block to reduced neuropathic pain descriptors after mastectomy
Eva M. Flores, Flavia Venetucci Gouveia, Márcio Matsumoto, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top